COMMUNIQUÉS West-GlobeNewswire

Les Canadiens souhaitent assister à des événements sportifs féminins professionnels. La plupart des amateurs ignorent cependant où les trouver.
27/10/2026
Une nouvelle étude de Femmes et sport au Canada révèle que la demande est avérée, mais que le manque de visibilité freine la prochaine phase de croissance du marché TORONTO, 27 oct. 2026 (GLOBE NEWSWIRE) -- Trois [...]
Canadians Want Professional Women’s Sport. Most Fans Don’t Know Where to Find it.
27/10/2026
New Canadian Women & Sport research finds demand is proven, but visibility is holding back the market’s next phase of growth TORONTO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Three in four Canadians (75%) now identify as [...]
Four Years After St. Paul Acquisition, Pro-Tech Design & Manufacturing Shows Medtech Consolidation Doesn't Have to Mean Disruption
27/10/2026
The St. Paul facility has shipped more than 3.5 million medical devices since joining Pro-Tech Design in 2022, while retaining 100% of its customers and 95% of its employees St. Paul, MN, Oct. 27, 2026 (GLOBE NEWSWIRE [...]
Bavarian Nordic to Supply and Donate Vaccines for Global Mpox Emergency Stockpile
27/10/2026
Bavarian Nordic donates 75,000 doses of MVA-BN ® and will also supply 150,000 doses to new global mpox vaccine emergency stockpile. Building emergency reserves is an important milestone in global mpox preparedness, [...]
Addition Therapeutics to Present Preclinical Data from PRINT™ Programs at the European Society of Gene & Cell Therapy’s (ESGCT) 33rd Annual Congress
27/10/2026
Addition continues to progress a novel pipeline of non-viral, LNP-delivered, RNA-only gene-addition therapies for severe, lifelong genetic and non-genetic diseases Company to present an oral presentation on the PRINT [...]
UK health tech pioneer Patients Know Best launches global expansion at HLTH Las Vegas
27/10/2026
Cambridge, UK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Patients Know Best (PKB) , the UK patient-controlled health record platform, will exhibit at HLTH Las Vegas (15–18 November, The Venetian Expo) as part of the UK [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2026
27/10/2026
DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l’article 222-12-5 du règlement général de l’AMF, les [...]
Ozari Health Named Cheapest Place to Buy Compounded Tirzepatide Online for 2026
27/10/2026
The national telehealth platform's $125-a-month compounded tirzepatide plan, with the clinician visit, medication and shipping in one published price and no membership fee, took first place in Venture Magazine's new [...]
Beeline Medicines to Present Results from the Phase 2 Trial of Afimetoran in Systemic Lupus Erythematosus as a Late-Breaking Oral Presentation at ACR Convergence 2026
27/10/2026
– Results demonstrate consistent improvements across measures of disease activity, quality of life, and pharmacodynamic markers, with a tolerable safety profile across all afimetoran dose groups – – Safety and efficacy [...]
Lenny Peters Cup Turns High Point, N.C., Into an International Rowing Destination
27/10/2026
Dutch Olympic champions defeat Team USA, while visitors, hotel bookings and local spending highlight the impact of sports philanthropy High Point, NC, Oct. 27, 2026 (GLOBE NEWSWIRE) -- What began as a regatta with two [...]
Enlivex Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal
27/10/2026
Nes-Ziona, Israel, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) ("Enlivex" or the "Company"), a quality longevity company powered by a prediction markets treasury, today announced receipt of a delisting [...]
Inhibikase Therapeutics Announces Participation in Upcoming Investor Conferences During November 2026
27/10/2026
WILMINGTON, Del., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001, a novel once-daily oral anti- [...]
Altimmune Appoints Peter Greenleaf and Alex Howarth, Two Leading Biotech Executives, to Board of Directors to Support Its Strategic Evolution
27/10/2026
Board appointments align with successful transition to late-stage clinical Company developing pemvidutide as a differentiated liver franchise with multiple potential indications As part of this transition, John M. Gill [...]
AssistRx Named a Central Florida Top Workplace for Sixth Consecutive Year
27/10/2026
Employee feedback-based recognition highlights AssistRx’s focus on growth, inclusion and wellness ORLANDO, Fla., Oct. 27, 2026 (GLOBE NEWSWIRE) -- AssistRx , the advanced therapy initiation and patient solutions [...]
Legend Biotech to Host Investor Conference Call on Third Quarter 2026 Results
27/10/2026
BRIDGEWATER N.J., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 a.m. ET on Tuesday, [...]
Madrigal to Present Multiple Abstracts at AASLD's The Liver Meeting 2026, Including New Real-World Evidence Reinforcing Rezdiffra as a Foundational Therapy for MASH
27/10/2026
Rezdiffra ® (resmetirom) to be featured in more abstracts than any other approved or investigational MASH therapy Real-world evidence abstracts examine Rezdiffra effectiveness, tolerability and treatment persistence in [...]
Calidi Biotherapeutics Presented New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026, Including Highlighting the Potential of its RedTail Gene Medicine Platform to Turn Tumors into Localized TCE Biofactories
27/10/2026
Single-dose CLD-401 induced tumor regression and complete response in 80% of mice in EMT6 breast tumor model Building on the growing clinical evidence supporting T-cell engagers in solid tumors, data showed the platform [...]
Helus Pharma Announces Co-Founders’ Transition from Executive Leadership as Company Advances Toward Next Stage of Development
27/10/2026
Co-founders to step down from executive roles and continue to serve on the Board of Directors Helus Pharma board member, Mark Lawson, appointed as new independent Chair of the Board of Directors, effective immediately [...]
Teva Acquires Worldwide Rights to BXCL501, Further Expanding Innovative Neuroscience Pipeline
27/10/2026
BXCL501, a dexmedetomidine sublingual film, is under FDA review for first-ever at-home use for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults Acquisition adds [...]

Pages